Improving Outcomes in Multiple Sclerosis: Implications for the Specialty Pharmacist

, ,
Specialty Pharmacy Times, Nov/Dec 2013, Volume 4, Issue 6

This activity is supported by educational grants from Biogen Idec and Genzyme, a Sanofi company.

Improving Outcomes in Multiple Sclerosis: Implications for the Specialty Pharmacist

Logan E. Davis, PharmD

Director of Franchise Development

Vital Care, Inc

Meridian, Mississippi

Laura Joiner, PharmD

PGY-1 Pharmacy Resident

Vital Care of Meridian

Meridian, Mississippi

Chris Newlin, PharmD

Project Manager

Residency Program Coordinator

Vital Care, Inc

Meridian, Mississippi

Disclosures

The following faculty, planners, and staff have no relevant financial relationships with commercial interests to disclose.

Faculty

Logan E. Davis, PharmD

Laura Joiner, PharmD

Chris Newlin, PharmD

Pharmacy Times Office of Continuing Professional Education Planning Staff—Judy V. Lum, MPA, and Steve Lin, PharmD, RPh

Pharmacy Times Editorial Staff— Kirk McKay and David Allikas

An anonymous peer reviewer was part of the content validation and conflict resolution process. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Objectives

At the conclusion of this educational activity, participants should be able to complete the following:

1. Examine the epidemiology, pathophysiology, and clinical progression of multiple sclerosis (MS).

2. Evaluate current and emerging therapeutic strategies for slowing disease progression in patients with MS and for their role in the treatment paradigm.

3. Describe common adverse events associated with MS therapies, as well as strategies for mitigating these side effects.

4. Identify the role of specialty pharmacists in maximizing outcomes in patients with MS.

Target audience: Specialty pharmacists

Type of activity: Knowledge

Release date: December 12, 2013

Expiration date: December 12, 2015

Estimated time to complete activity: 1.5 hours

Fee: This lesson is offered free online at www.pharmacytimes.org. There is a nominal fee of $10.00 for mailed/faxed evaluation and exam forms.

Click here to view this activity.

Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEUs) under the ACPE universal activity number 0290-0000-13-166-H01-P. The activity is available for CE credit through December 12, 2015.